As a novel tumor-related lncRNA, dysregulation of MAFG‐AS1 contributes to multiple human cancers, including breast cancer, lung cancer, liver cancer, bladder cancer, colorectal cancer, gastric cancer, esophagus cancer, prostate cancer, pancreatic cancer, ovarian cancer, and glioma. This evidence concerns the gene MAFG and central nervous system cancer.